Yahoo Finance Milan Zdravkovic of Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Just Spent kr3.0m On Shares
Potential Swedish Orphan Biovitrum AB (publ) (STO:SOBI) shareholders may wish to note that insider Milan Zdravkovic recently bought kr3.0m worth of stock, paying kr213 for each share. We reckon that's a good sign, especially since the purchase boosted their holding by 157%.
View our latest analysis for Swedish Orphan Biovitrum
Swedish Orphan Biovitrum Insider Transactions Over The Last Year
Notably, that recent purchase by Milan Zdravkovic is the biggest insider purchase of Swedish Orphan Biovitrum shares that we've seen in the last year. That means that an insider was happy to buy shares at above the current price of kr203. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.
Swedish Orphan Biovitrum insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Does Swedish Orphan Biovitrum Boast High Insider Ownership?
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that Swedish Orphan Biovitrum insiders own about kr78m worth of shares (which is 0.1% of the company). Whilst better than nothing, we're not overly impressed by these holdings.
So What Do The Swedish Orphan Biovitrum Insider Transactions Indicate?
It is good to see recent purchasing. And the longer term insider transactions also give us confidence. Insiders likely see value in Swedish Orphan Biovitrum shares, given these transactions (along with notable insider ownership of the company). While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 2 warning signs with Swedish Orphan Biovitrum and understanding them should be part of your investment process.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.
